BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8091883)

  • 1. [Prevention of thrombosis in minimally invasive surgery].
    Harenberg J
    Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
    Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies].
    Koppenhagen K; Tröster E; Matthes M; Häring R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1163-6. PubMed ID: 1983504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
    Daiss W; Dölle W
    Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulatory prevention of thrombosis in a traumatologic patient sample].
    Wolf N; Meiser H; Berg U; Goedicke M; Simonis G
    Vasa Suppl; 1992; 35():109. PubMed ID: 1336217
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
    Hamann H
    Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fully automated injection pen for prevention of thrombosis. Tolerance, convenience and patient compliance].
    Höntzsch D; Scheffer J; Hafner S; Spannagel U; Tolle A
    MMW Fortschr Med; 1999 Jul; 141(26):50. PubMed ID: 10897931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk factors of thrombotic complications in laparoscopic operations and their prevention].
    Sedov VM; Salov AB
    Vestn Khir Im I I Grek; 2004; 163(3):11-3. PubMed ID: 15317153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative deep venous thrombosis (DVT) and low-molecular weight heparin (LMWH) type and dosage.
    Wicky J; Couson F; Ambrosetti P; Didier D; Rohner A; Bounameaux H
    Thromb Haemost; 1993 Apr; 69(4):402-3. PubMed ID: 8388582
    [No Abstract]   [Full Text] [Related]  

  • 11. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How is the use of low molecular weight heparin in regional anesthesia evaluated?].
    Dennhardt R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1171-3. PubMed ID: 1983507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
    Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
    Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
    Slunsky R
    Zentralbl Gynakol; 1995; 117(11):598-601. PubMed ID: 8533494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Hirsh J
    N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
    [No Abstract]   [Full Text] [Related]  

  • 16. [When long-term marcumar administration is needed. Low-molecular-weight heparin bridges the surgery gap].
    MMW Fortschr Med; 2001 Feb; 143(8):52. PubMed ID: 11265545
    [No Abstract]   [Full Text] [Related]  

  • 17. [Topical administration of unfractionated and low molecular weight heparin for prevention of appositional thrombus formation].
    Koppenhagen K; Häring R; Proksch W; Erdmann K; Leick M; Bundrock P; Franke J
    Vasa Suppl; 1992; 35():99-100. PubMed ID: 1336219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
    Agnelli G; Cimminiello C
    Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
    [No Abstract]   [Full Text] [Related]  

  • 19. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can thrombosis be prevented through immediate postoperative low-molecular-weight-heparin prophylaxis?].
    Bank I; Büller HR
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2031. PubMed ID: 11072524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.